Wegovy maker Novo Nordisk has hired the start-up Deep Apple Therapeutics to develop small molecules as its next weight-loss ...

"Let's say you wake up really hungry," says Lembas CTO Dr. Zohar Barbash. "You take the peptide and feel like you have just ...

Peptides are among the most intriguing biomolecules investigated in scientific research. Despite their relatively simple ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

New research led by scientists at the University of Birmingham suggests that treating psoriasis with a tripeptide-composed of ...

They can be stimulated by exogenous nitric oxide donors and natriuretic peptides, although these ... Here, we focus on new developments with small-molecule inhibitors of cardiac hypertrophy ...

RAD101 is the Company's novel imaging small molecule that targets fatty acid synthase (FASN), a multi-enzyme protein that ...

Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.

The quickly evolving development of biopharmaceuticals is impacting innovation in the industry overall.

Oxeltis, a Contract Research Organization (CRO), and Molecular Forecaster Inc. (MFI), a computational chemistry company, today announce their strategic partnership, leveraging the strengths of both ...

New research shows the symbiotic relationship between plant roots and soil fungi, leading to reduced chemical use and ...